XML 29 R23.htm IDEA: XBRL DOCUMENT v3.25.3

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2025

Stockholders' Equity Note [Abstract]

Summary of Warrants Activity

The following summarizes warrant activity during the nine months ended September 30, 2025 and 2024:

		Number of Common Warrants				Number of Pre-funded Warrants				Weighted-Average Exercise Price
Balances as of December 31, 2024			8,104,615				38,543,577
Issued			—				—			$	—
Exercised			—				—			$	—
Expired			(1,226,993	)			—			$	5.807
Balances as of September 30, 2025			6,877,622				38,543,577

		Number of Common Warrants				Number of Pre-funded Warrants				Weighted-Average Exercise Price
Balances as of December 31, 2023			8,427,508				40,492,923
Issued			—				7,000,000			$	0.001
Exercised			(322,893	)			(6,209,871	)		$	0.307
Balances as of September 30, 2024			8,104,615				41,283,052

Schedule of Common Stock Reserved for Future Issuance

The Company reserved the following shares of common stock for issuance as follows:

		September 30, 2025				December 31, 2024
Stock options issued and outstanding			19,381,754				14,594,720
Stock options reserved for 2020 Incentive Award Plan			1,053,719				2,109,758
Unvested restricted stock units outstanding			1,308,942				770,028
Common stock reserved for 2024 ATM program			19,014,041				24,250,000
Common stock reserved for Employee Stock Purchase Plan			2,959,996				1,983,924
Common stock reserved for 2022 Employment Inducement     Award Plan			3,077,259				3,359,230
Common stock reserved for pre-funded warrants			38,543,577				38,543,577
Common stock reserved for common warrants			6,877,622				8,104,615
Total common stock reserved			92,216,910				93,715,852

X

- Definition

Schedule of common stock reserved for future issuance table.

+ References

No definition available.

+ Details

Name:	annx_ScheduleOfCommonStockReservedForFutureIssuanceTableTableTextBlock
Namespace Prefix:	annx_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration